Stroke is a leading cause of morbidity and mortality worldwide. Early recognition and immediate intervention can significantly improve patient outcomes. This article aims to provide healthcare professionals with a comprehensive understanding of the early signs of stroke and its management.
Stroke presents with sudden onset neurological deficits. The most common symptoms include facial drooping, arm weakness, and speech difficulties - remembered by the acronym FAST. Other symptoms may involve sudden confusion, trouble seeing, difficulty walking, or severe headache. Timely identification of these symptoms is critical to initiate rapid stroke care.
Several validated scales like the National Institutes of Health Stroke Scale (NIHSS) and the Cincinnati Prehospital Stroke Scale (CPSS) are available to assess the severity of stroke and guide treatment decisions. These tools can help stratify patients, predict outcomes, and facilitate communication between healthcare providers.
Upon suspicion of stroke, immediate medical attention is paramount. Initial management focuses on stabilizing the patient, maintaining airway, breathing, and circulation. Rapid neuroimaging, preferably with a non-contrast CT scan, should be performed to differentiate between ischemic and hemorrhagic stroke.
Intravenous thrombolysis with alteplase is the treatment of choice for eligible patients with acute ischemic stroke. It should be administered within 4.5 hours of symptom onset. However, the sooner the treatment, the better the outcomes, emphasizing the principle of 'time is brain'.
Early recognition and management of stroke can significantly reduce morbidity and mortality. Healthcare professionals should be well-versed with the early signs of stroke, assessment tools, and initial management strategies to provide timely and effective care. Remember, in stroke care, every second counts.
1.
The need for more Latinx participants in Alzheimer's trials is urgent.
2.
Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa
3.
Disparities in use of MRI to detect prostate cancer: Race and location may influence testing
4.
In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?
5.
Study offers clearer picture of childhood brain tumor survival
1.
Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers
2.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
3.
Comprehensive Standards in Oncology for Modern Medicine
4.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
5.
Practical Standards in Hematology for Healthcare Excellence
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
4.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation